Late Stage Gp Ltd. Pontifax serves as Executive at Keros Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Late Stage Gp Ltd. Pontifax has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 29, 2022 involved exercising options for 1,723 shares valued at $0.
Late Stage Gp Ltd. Pontifax currently holds 1,121,045 shares of Keros Therapeutics, Inc. (KROS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Late Stage Gp Ltd. Pontifax has been a net neutral trader of KROS stock. They have purchased $0 and sold $0 worth of shares.
Late Stage Gp Ltd. Pontifax's most recent insider trade was on Nov 29, 2022, when they sold 1,723 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 29, 2022 | KROS | $0 | Exercise | 1,914 | $N/A | Discretionary |